Skip to main content

Table 5 Multivariable Cox regression analysis for OS including cumulative cisplatin dose; landmark analysis only including patients alive 8 weeks after end of treatment

From: 3-weekly or weekly cisplatin concurrently with radiotherapy for patients with squamous cell carcinoma of the head and neck – a multicentre, retrospective analysis

Factor

Hazard ratio

95% Confidence interval

p-value

Cumulative cisplatin dose

1.25

0.84–1.87

0.263

Gender

1.05

0.66–1.67

0.821

Age at diagnosis

1.02

1.00–1.05

0.012

Hypopharyngeal localisation

1.09

0.66–1.80

0.735

Smoking history

1.98

0.91–4.31

0.082

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us